4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001415889-21-002499
CEO bought 10,000 shares at $6.65 ($66,500)
From the SEC's structured data for this filing
Trades in this filing
Fried Robert N · CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-05-13 | Purchase : show line 1 in the form | +10,000 | $6.65 | $66,500 | 63,001 | I |
| Open-market purchases · 10,000 sh · avg $6.65 · $66,500 | ||||||
Loading xslF345X03/form4-05172021_080502.xml…